The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.

Rodrigo Bueno de Oliveira,Sophie Liabeuf,Hirokazu Okazaki,Aurelie Lenglet,Lucie Desjardins,Horst-Dieter Lemke,Raymond Vanholder,Gabriel Choukroun,Ziad A Massy

Clinical kidney journal（2013）

引用 13|浏览16

暂无评分

摘要

Our study was the first to demonstrate a significant, independent link between leptin and MS (but not clinical outcomes) and PTH in patients at different CKD stages. Future studies will have to assess the involvement of leptin in MS and clinical outcomes in CKD, and the potential modulation of leptin by PTH.

查看译文

关键词

adiponectin,chronic kidney disease,leptin,metabolic syndrome,parathormone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要